| __timestamp | Amicus Therapeutics, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 47624000 | 19586000 |
| Thursday, January 1, 2015 | 76943000 | 29135000 |
| Friday, January 1, 2016 | 104793000 | 42791000 |
| Sunday, January 1, 2017 | 149310000 | 49577000 |
| Monday, January 1, 2018 | 270902000 | 89209000 |
| Tuesday, January 1, 2019 | 286378000 | 69099000 |
| Wednesday, January 1, 2020 | 308443000 | 75961000 |
| Friday, January 1, 2021 | 272049000 | 90467000 |
| Saturday, January 1, 2022 | 276677000 | 74552000 |
| Sunday, January 1, 2023 | 152381000 | 91593000 |
Data in motion
In the competitive landscape of pharmaceutical innovation, research and development (R&D) spending is a critical indicator of a company's commitment to future growth. Over the past decade, Amicus Therapeutics and Supernus Pharmaceuticals have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Amicus Therapeutics consistently outpaced Supernus Pharmaceuticals, with its R&D expenses peaking in 2020 at nearly 300% higher than its 2014 levels. In contrast, Supernus Pharmaceuticals showed a more modest increase, with its R&D spending in 2023 being approximately 370% of its 2014 expenditure. This divergence highlights Amicus's aggressive pursuit of innovation, while Supernus adopts a more conservative approach. As the pharmaceutical industry continues to evolve, these spending patterns may offer insights into each company's future trajectory and potential breakthroughs.
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Alnylam Pharmaceuticals, Inc. vs Amicus Therapeutics, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
Research and Development Investment: Pharming Group N.V. vs Amicus Therapeutics, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
R&D Insights: How Verona Pharma plc and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Expenses Breakdown: ADMA Biologics, Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: ACADIA Pharmaceuticals Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Amicus Therapeutics, Inc. vs Iovance Biotherapeutics, Inc.
Research and Development Investment: Amicus Therapeutics, Inc. vs Viridian Therapeutics, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.